Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1992-11-16
1994-02-15
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
536 245, A61K 3170, C07H 1700
Patent
active
052867170
ABSTRACT:
Phosphorothioate oligodeoxyribonucleotide analogs can be used to prevent replication of foreign nucleic acids in the presence of normal living cells, as well as to inhibit the proliferation of neoplastic cells.
REFERENCES:
patent: 3687808 (1972-08-01), Merigan, Jr. et al.
patent: 4469863 (1984-09-01), Ts'o et al.
patent: 4511713 (1985-04-01), Miller et al.
J. Amer. Chem. Soc. 106:6077 (1984).
J. Biochem. Biophys. Methods 13:97-102 (1986).
Biochem. Biophys. Res. Comm. 140(2):735-742.
Cancer Research 45(9):4677s-4684s (1985).
J. Chromatography 326:263-280 (1985).
Nucleic Acids Research 14(22):9081-9093 (1986).
J. Org. Chem. 49:2314-2317 (1984).
J. Org. Chem. 50(20):3908-3913 (1985).
Proc. Natl. Acad. Sci. USA 83:2787-2791 (1986).
Proc. Natl. Acad. Sci. USA 83:4143-4146 (1986).
Proc. Natl. Acad. Sci. USA 84:7706-7710 (1987).
Proceedings of the NATO Advanced Study Institute on Targets for the Design of Antiviral Agents 1984, 259-285.
Tetrahedron Letters 23: (41) 4289-4292 (1982).
Yarchoan et al., Scientific American, vol. 259, pp. 110-119 (1988).
Matsukura et al., Proc. Natl. Acad. Sci., vol. 86, pp. 4244-4248 (1989).
Woolf et al., Nucleic Acids Research, vol. 18, pp. 1763-1769 (1990).
Leiter et al., Proc. Natl. Acad. Sci., vol. 87, pp. 3430-3434 (1990).
Manson et al., Lymphokine Research, vol. 9, pp. 35-42 (1990).
McManaway et al., Lancet, vol. 335, pp. 808-811 (Apr. 7, 1990).
Sankar et al., Eur. J. Biochem., vol. 184, pp. 39-45 (1989).
Agrawal et al., Proc. Natl. Acad. Sci., vol. 86, pp. 7790-7794 (1989).
Lennette, Laboratory Diagnosis of Viral Infections, pp. 47-48 (Marcel Dekker, New York, 1985).
Mitsuya et al., Proc. Natl. Acad. Sci., vol. 82, pp. 7096-7100 (1985).
Yarchoan et al., Lancet, pp. 575-580 (Mar. 15, 1986).
Broder, editor, AIDS: Modern Concepts and Therapeutic Challenges, Chapters 18 and 19 (Marcel Dekker, New York, 1987).
Stringfellow, editor, Interferon and Interferon Inducers, Chapters 7 and 10 (Marcel Dekker, New York, 1980).
Gerwirtz, A. M., et al., "A c-myb Antisense Oligodeoxynucleotide Inhibits Normal Human Hematopoiesis in Vitro," Science 242:1303-1306 (Dec. 2, 1988).
Sagata, N., et al., "Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes,"Nature 335:519-525 (Oct. 6, 1988).
Reed, J. C., et al., "Antisense-mediated Inhibition of BCL2 Protooncogene Expression and Leukemic Cell Growth and Survival: Comparisons of Phosphodiester and Phosphorothioate Oligodeoxynucleotides," Cancer Research 50:6565-6570 (Oct. 15, 1990).
L. LaPlanch et al., Nucleic Acid Res. 14(22):9081-9093, 1986.
Cohen Jack S.
Loke She L.
Neckers Len
Shinozuka Kazuo
Stein Cy
Rollins John W.
The United States of America as represented by the Department of
LandOfFree
Inhibitors for replication of retroviruses and for the expressio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors for replication of retroviruses and for the expressio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors for replication of retroviruses and for the expressio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1207116